Elevation of serum creatinine is a delayed marker of graft rejection. Using a combination of biomarkers at the cellular, transcription and molecular level will allow us to earlier identify graft rejection and intervene before irreversible damage occurs.
Dr. Leonardo V. Riella is an Assistant Professor of Medicine at Harvard Medical School and a Physician-Scientist at the Brigham and Women’s Hospital (BWH) in Boston.
He is Associate Director of Kidney Transplantation, Associate Member of Broad Institute of Harvard and MIT and Associate Editor of the American Journal of Transplantation.
Dr. Riella’s research is focused on understanding the mechanisms of immune regulation and on the development of novel therapies to promote organ tolerance.